Navigation Links
Myoderm Selects Tracie DiPasquale To Lead CentralSource
Date:1/8/2013

Norristown, PA (PRWEB) January 08, 2013

Myoderm, a global leader in sourcing commercial drugs for clinical trials, is pleased to announce that Tracie DiPasquale has joined the company as Director, CentralSource. She will work out of Myoderm’s US office.

Myoderm is fortunate to have someone with Tracie’s background and qualifications to direct CentralSource, the company’s turnkey sourcing, distribution, and management service that supplies individual sites directly on an as-needed basis. For over a decade, she managed business development efforts and implemented supply chain strategies for leading pharmaceutical firms, including Pfizer and Almac. Her diversified experience with both large and small pharmaceutical companies gives her the insight and flexibility to exceed clients’ needs.

A graduate of the University of Pittsburgh, with a B.Sc. degree in Natural Sciences and a minor in Biology, Tracie offers Myoderm customers a unique understanding of global clinical site drug supply management and oversight issues.

Mike Cohen, Managing Director of Myoderm, says, “Tracie’s experience from both the service and client sides gives her an invaluable perspective on sourcing issues and makes her a superb advocate for Myoderm clients.”

About Myoderm
Myoderm is a leader in the sourcing, distribution, and management of commercial pharmaceutical products and supplies for clinical trials and biosimilar research. The company’s clients span the globe and include biotech, CROs, clinical trial packagers, and the majority of the world’s top10 pharmaceutical companies. With its deep expertise, customized solutions, and commitment to personalized service, Myoderm provides the optimal drug supply solution for global clinical studies.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10292730.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCAN Selects Defran Systems to Support its Wide Range of Youth and Family Programs
2. President Obama selects Rutgers cell biologist Nihal Altan-Bonnet to receive prestigious award
3. The Gerontological Society of America Selects 2012 Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst nurses and professionals in ... lights on the variety of topics detailing why we appreciate nurses in so many ... career has gone from being in a major recession to one of the hottest ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated a new ... This is the first time that Coolsculpting is being used for for more than ... to ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... Georgia (PRWEB) , ... May 26, 2016 , ... ... certificate in intellectual property (IP) to its specialty academic programs. , Answering to ... the college’s existing certificate programs in health law, and environmental and land use ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are nearly 14.5 ... 32 million cancer survivors worldwide. On Sunday, June 5, 2016, communities around the world ... Cancer Survivors Day®. , National Cancer Survivors Day® is an annual worldwide Celebration ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... According to a new market ... 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application ... Manufacturers, Hospitals/ Clinics) - Forecast to 2021", published by ... for the forecast period of 2016 to 2021. This ... 2021 from USD 117.3 Million in 2016, at a ...
(Date:5/25/2016)... 2016 According to market research ... and Demand Forecast to 2022 - Industry Insights by ... published by P&S Market Research, the global insulin delivery ... and it is expected to grow at a CAGR ... pump segment is expected to witness the fastest growth ...
(Date:5/25/2016)... Inivata, a global clinical ... tumour DNA (ctDNA) analysis to improve personalised healthcare ... Clive Morris as Chief Medical Officer. ... development programme, scientific collaborations, and through to commercialisation ... in clinical outcomes for patients. Clive ...
Breaking Medicine Technology: